American Biosurgical Adds David Brazeal, CPA as Chief Financial Officer

NORCROSS, Ga., July 21 /PRNewswire/ -- American Biosurgical, a global leader in the custom medical cable market announced today that David Brazeal, CPA has joined the company as Chief Financial Officer. As CFO, David will report to Joe McGhee, Chairman and Chief Executive Officer and will have...

Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results

...ition, the Company completed the acquisition of Omrix Biopharmaceuticals, Inc., a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products. Also in the quarter, the Company entered into a definitive agreement to acquire Mentor Corporation, a leading supplie...

Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors

...continue to make progress toward initiating a pivotal Phase II/III clinical trial for our lead product candidate, Hemaseel(R)HMN (fibrin sealant), for biosurgical hemostasis" concluded Mr. Galli. From 2003-2005, Dr. Lynch served as Vice President, Regulatory Affairs and Quality Assurance at CryoLife, Inc., a m...

Epicel(TM) Wins Marketing Approval for Severe Burn Victims

...sed that the FDA has recognized the importance of Epicel for patients with severe burns," said Alicia Secor, vice president and general manager of the biosurgical Specialties group within Genzyme that manufactures Epicel. "Epicel has played a critical role in the recovery process of hundreds of patients who have...

Biosurgical in Medical Technology

Haemacure Announces Preliminary Findings of its Plasma Discard Analysis

...emostats for surgical use. Haemacure's lead product candidate, Hemaseel(TM)HMN, an all-human fibrin sealant, is in late stage clinical development for biosurgical applications. The second product, an all-human thrombin, a component of fibrin sealant, also has applications as a stand-alone product in the expandin...

Biosurgical in Medical Products

Sepramesh Biosurgical Composite

Description: Sepramesh Biosurgical Composite is designed for the repair of abdominal hernias. It consists of a PPM mesh that has two distinct sides. One side of the mesh is coated with a layer of sodium hyaluronate and carboxymethylcellulose (similar to Genzyme Biosurgery's Seprafilm® Adhesion Barrier). Th...
Company:Genzyme Biosurgery

Biosurgical in Biological Technology

Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.

...tion of its previously announced acquisition of Omrix Biopharmaceuticals, Inc., a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products. Omrix is expected to operate as a stand-alone entity reporting through ETHICON, Inc., a Johnson & Johnson company. ...

Johnson & Johnson Announces Definitive Agreement to Acquire Omrix

...p; Johnson (NYSE: JNJ ) and Omrix Biopharmaceuticals, Inc. (Nasdaq: OMRI ), a fully integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, today announced a definitive agreement whereby Omrix will be acquired for approximately $438 million in a cash tender offe...

Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States

...t (add-on) therapy for prevention and treatment of surgical site infections (SSIs) in the United States. This agreement is expected to add to Baxter's biosurgical portfolio by giving surgeons an innovative option to help reduce risk of post-operative complications of SSIs during surgery. The collagen-based imp...